Capricor Therapeutics (CAPR) Restructuring Costs (2024 - 2025)
Capricor Therapeutics (CAPR) recorded quarterly Restructuring Costs of $2.6 million in Q3 2025, up 128.93% quarter-over-quarter from $1.1 million in Q3 2024, and up 128.93% on a YoY basis from $1.1 million in Q3 2024.
Capricor Therapeutics (CAPR) Restructuring Costs (2024 - 2025) Analysis & Trends
Capricor Therapeutics' Restructuring Costs history runs 2 years deep, the most recent figure standing at $2.6 million for Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - |
| 10 | Capricor Therapeutics | 1.53 Bn | 1.26 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 2.61 Mn |
| Sep 30, 2024 | 1.14 Mn |